258 related articles for article (PubMed ID: 15079814)
1. Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle.
Brooks AR; Harkins RN; Wang P; Qian HS; Liu P; Rubanyi GM
J Gene Med; 2004 Apr; 6(4):395-404. PubMed ID: 15079814
[TBL] [Abstract][Full Text] [Related]
2. p53 adenoviral vector (Ad-CMV-p53) induced prostatic growth inhibition of primary cultures of human prostate and an experimental rat model.
Shirakawa T; Gotoh A; Gardner TA; Kao C; Zhang ZJ; Matsubara S; Wada Y; Hinata N; Fujisawa M; Hanioka K; Matsuo M; Kamidono S
J Gene Med; 2000; 2(6):426-32. PubMed ID: 11199263
[TBL] [Abstract][Full Text] [Related]
3. Promoters influence the kinetics of transgene expression following adenovector gene delivery.
Chen P; Tian J; Kovesdi I; Bruder JT
J Gene Med; 2008 Feb; 10(2):123-31. PubMed ID: 18064718
[TBL] [Abstract][Full Text] [Related]
4. CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression.
Liu BH; Wang X; Ma YX; Wang S
Gene Ther; 2004 Jan; 11(1):52-60. PubMed ID: 14681697
[TBL] [Abstract][Full Text] [Related]
5. Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.
Wang CY; Guo HY; Lim TM; Ng YK; Neo HP; Hwang PY; Yee WC; Wang S
J Gene Med; 2005 Jul; 7(7):945-55. PubMed ID: 15756650
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation of cytomegalovirus major immediate-early promoter activity in transgenic mice.
Mehta AK; Majumdar SS; Alam P; Gulati N; Brahmachari V
Gene; 2009 Jan; 428(1-2):20-4. PubMed ID: 18976699
[TBL] [Abstract][Full Text] [Related]
7. Complete correction of hyperbilirubinemia in the Gunn rat model of Crigler-Najjar syndrome type I following transient in vivo adenovirus-mediated expression of human bilirubin UDP-glucuronosyltransferase.
Askari FK; Hitomi Y; Mao M; Wilson JM
Gene Ther; 1996 May; 3(5):381-8. PubMed ID: 9156798
[TBL] [Abstract][Full Text] [Related]
8. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter.
Yew NS; Przybylska M; Ziegler RJ; Liu D; Cheng SH
Mol Ther; 2001 Jul; 4(1):75-82. PubMed ID: 11472109
[TBL] [Abstract][Full Text] [Related]
9. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
[TBL] [Abstract][Full Text] [Related]
10. Increased level and duration of expression in muscle by co-expression of a transactivator using plasmid systems.
Li S; MacLaughlin FC; Fewell JG; Li Y; Mehta V; French MF; Nordstrom JL; Coleman M; Belagali NS; Schwartz RJ; Smith LC
Gene Ther; 1999 Dec; 6(12):2005-11. PubMed ID: 10637452
[TBL] [Abstract][Full Text] [Related]
11. Strain-specific rate of shutdown of CMV enhancer activity in murine liver confirmed by use of persistent [E1(-), E2b(-)] adenoviral vectors.
Everett RS; Evans HK; Hodges BL; Ding EY; Serra DM; Amalfitano A
Virology; 2004 Jul; 325(1):96-105. PubMed ID: 15231389
[TBL] [Abstract][Full Text] [Related]
12. Silencing of fat-1 transgene expression in sheep may result from hypermethylation of its driven cytomegalovirus (CMV) promoter.
Duan B; Cheng L; Gao Y; Yin FX; Su GH; Shen QY; Liu K; Hu X; Liu X; Li GP
Theriogenology; 2012 Sep; 78(4):793-802. PubMed ID: 22541322
[TBL] [Abstract][Full Text] [Related]
13. Enhanced transgene expression in the mouse skeletal muscle infected by the adeno-associated viral vector with the human elongation factor 1alpha promoter and a human chromatin insulator.
Mori-Uchino M; Takeuchi T; Murakami I; Yano T; Yasugi T; Taketani Y; Nakagawa K; Kanda T
J Gene Med; 2009 Jul; 11(7):598-604. PubMed ID: 19399759
[TBL] [Abstract][Full Text] [Related]
14. Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations.
Magnusson T; Haase R; Schleef M; Wagner E; Ogris M
J Gene Med; 2011 Jul; 13(7-8):382-91. PubMed ID: 21721074
[TBL] [Abstract][Full Text] [Related]
15. Activator protein 1-mediated transcriptional regulation strategy sustains long-term expression of a xenogeneic gene product in vivo: an implication for gene therapy targeting congenital protein deficiencies.
Sasaki S; Smith JM; Takase K; Okuda K; Ishii N; Takeshita F
Int J Mol Med; 2006 Aug; 18(2):289-97. PubMed ID: 16820937
[TBL] [Abstract][Full Text] [Related]
16. Adenoviral-mediated skeletal muscle transcriptional targeting using chimeric tissue-specific promoters.
Frauli M; Ribault S; Neuville P; Augé F; Calenda V
Med Sci Monit; 2003 Feb; 9(2):BR78-84. PubMed ID: 12601283
[TBL] [Abstract][Full Text] [Related]
17. Methylation analysis of the promoter F of estrogen receptor alpha gene: effects on the level of transcription on human osteoblastic cells.
Penolazzi L; Lambertini E; Giordano S; Sollazzo V; Traina G; del Senno L; Piva R
J Steroid Biochem Mol Biol; 2004 Jun; 91(1-2):1-9. PubMed ID: 15261302
[TBL] [Abstract][Full Text] [Related]
18. Muscle stem cells can act as antigen-presenting cells: implication for gene therapy.
Cao B; Bruder J; Kovesdi I; Huard J
Gene Ther; 2004 Sep; 11(17):1321-30. PubMed ID: 15175641
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation dependent silencing of the human glutamate transporter EAAT2 gene in glial cells.
Zschocke J; Allritz C; Engele J; Rein T
Glia; 2007 May; 55(7):663-74. PubMed ID: 17311293
[TBL] [Abstract][Full Text] [Related]
20. Astrocytic expression of transgene in the rat brain mediated by baculovirus vectors containing an astrocyte-specific promoter.
Wang CY; Wang S
Gene Ther; 2006 Oct; 13(20):1447-56. PubMed ID: 16724097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]